Crossmark

The Sec61 translocon is a therapeutic vulnerability in multiple myeloma

Crossref DOI link: https://doi.org/10.15252/emmm.202114740

Published Online: 2022-01-11

Published Print: 2022-03-07

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Domenger, Antoine

Choisy, Caroline

Baron, Ludivine

Mayau, Véronique

Perthame, Emeline

Deriano, Ludovic https://orcid.org/0000-0002-9673-9525
Arnulf, Bertrand

Bories, Jean‐Christophe

Dadaglio, Gilles https://orcid.org/0000-0003-3848-0823
Demangel, Caroline https://orcid.org/0000-0001-7848-586X
License Information

Version of Record valid from 2022-01-11
More Information

Publication History

Received: 2021-06-18

Accepted: 2021-12-22

Published: 2022-01-11